Skip to main content

Tate & Lyle Ventures invests in Evolve BioSystems for newborn probiotics & prebiotics

Evolve BioSystems is receiving a $2 million investment from Tate & Lyle Ventures to support Evolve’s ongoing clinical activities and preparations for commercial launch of its novel probiotic and prebiotic products.



from NutraIngredients RSS http://ift.tt/1NA3a77
via IFTTT

Popular posts from this blog

Photo

from Bodybuilding Motivation http://ift.tt/2EtKRn5 via IFTTT